Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tissue Regeneration Systems developed a proprietary 3D printed scaffold platform for skeletal reconstruction and bone regeneration. The technology was validated in vitro, in vivo, including large animal trials with promising long-term results. The company completed all required bench and animal testing, received FDA 510K clearance for its first commercial product, but ultimately pursued a corporate partnership model. Its core technology was acquired by DePuy Synthes Products (Johnson & Johnson) in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tissue Regeneration Systems.